ID   Ma-Mel-61f
AC   CVCL_S668
DR   cancercelllines; CVCL_S668
DR   Cosmic; 2686450
DR   Wikidata; Q54903832
RX   PubMed=23348503;
CC   Sequence variation: Gene deletion; HGNC; 6190; JAK1; Zygosity=Heterozygous (from autologous cell line Ma-Mel-61a).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=23348503).
CC   Derived from site: Metastatic; Not specified.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_C291 ! Ma-Mel-61a
OI   CVCL_C292 ! Ma-Mel-61b
OI   CVCL_S666 ! Ma-Mel-61c
OI   CVCL_S667 ! Ma-Mel-61e
OI   CVCL_S669 ! Ma-Mel-61g
OI   CVCL_S670 ! Ma-Mel-61h
SX   Male
AG   31Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 12
//
RX   PubMed=23348503; DOI=10.1126/science.1230062;
RA   Horn S., Figl A., Rachakonda P.S., Fischer C., Sucker A., Gast A.,
RA   Kadel S., Moll I., Nagore E., Hemminki K., Schadendorf D., Kumar R.;
RT   "TERT promoter mutations in familial and sporadic melanoma.";
RL   Science 339:959-961(2013).
//